by Richard Daverman, PhD
August 27, 2013 -- Winteam Pharma will sell its 51% stake in Guizhou Zhongtai Biological Technology for 101 million RMB ($16.5 million), representing a small gain of $2.5 million. Zhongtai is a plasma-based biopharma with operations in mainland China. In May, Winteam boughtTongjitang Chinese Medicines, paying $393 million, making it seem likely that Winteam is raising cash and focusing its operations. More details....
Stock Symbol: (HK: 00570)
Help employers find you! Check out all the jobs and post your resume.
